Patents
Patents for C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924)
02/2015
02/11/2015CN104350045A 用于治疗涉及调节兰诺定受体的调节障碍的活性剂 For the treatment involves adjusting the ryanodine receptor dysregulation of active agent
02/11/2015CN102858159B 化合物 Compound
02/05/2015WO2015017412A1 11-oxo-10,11-dihydrodibenzo[b,f][1,4]thiazepine s-oxide derivatives and their use as dopamine d2 receptor antagonists
02/03/2015US8946224 Substituted [1,2,4]triazolo[4,3-A]pyrazines for medicaments and pharmaceutical compositions
01/2015
01/27/2015US8940722 Compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORγ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune disease
12/2014
12/25/2014US20140378437 Agents for treating disorders involving modulation of ryanodine receptors
12/24/2014CN102131791B 二苯并硫杂氮杂*衍生物及其用途 Dibenzo-thiazepine derivatives and their use *
12/04/2014US20140356292 In vivo screening method of therapeutic agent for memory/learning dysfunctions by schizophrenia
11/2014
11/25/2014US8895548 Pharmaceutical composition for treating alzheimer's disease
10/2014
10/30/2014US20140323412 Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease
10/07/2014US8853198 Agents for treating disorders involving modulation of ryanodine receptors
10/07/2014US8852846 Salt and photoresist composition comprising the same
10/02/2014WO2014155387A1 Extended release dosage forms of quetiapine salts
09/2014
09/16/2014US8835438 Method of treating memory/learning dysfunctions caused by schizophrenia with lurasidone
09/04/2014WO2014131825A1 Pharmaceutical formulations comprising quetiapine and escitalopram
09/03/2014EP2772254A2 Novel Antibacterial Agents
08/2014
08/28/2014US20140243317 Dibenzothiazepine derivatives and their use in the treatment of cns disorders
08/28/2014US20140243281 Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases
08/21/2014WO2014125444A1 Heterocyclic amides as kinase inhibitors
08/13/2014EP2764867A1 Agents for preventing and treating disorders Involving modulation of the RYR receptors
07/2014
07/31/2014WO2013112809A3 Rifaximin derivative and uses thereof
07/24/2014US20140206666 Sulfamoylbenzamide derivatives as antiviral agents against hbv infection
07/23/2014CN103936690A 氨基二氢噻嗪衍生物 Aminodihydrothiazine derivatives
07/10/2014WO2014057439A3 Compositions and methods for treatment of neurological diseases and its associated complications
07/10/2014WO2014030106A3 Process for procuding (2r,3s)-3-(4-methoxyphenyl)glydidic acid ethyl ester by enantioselective hydrolysis of racemic 3(4-methoxyphenyl)glycidic acid methyl ester employing lipase derived from serratia marcescens and/or candida cylindracea
07/03/2014US20140187536 Agents for preventing and treating disorders involving modulation of the ryanodine receptors
07/01/2014US8765732 Aryl- or heteroaryl-substituted benzene compounds
05/2014
05/28/2014EP2735569A1 Method for producing lanthionine derivative
05/21/2014CN103804320A 一种Vilsmeier试剂参与的11-氯二苯并[b, f][1,4]硫氮杂卓的制备方法 11- chlorine Vilsmeier reagent diphenyl one kind of participation and [b, f] [1,4] The preparation method benzothiazepines
05/14/2014CN103788014A 制备10H-二苯并[b,f][1,4]硫氮杂卓-11-酮和喹硫平的方法 Preparation 10H- dibenzo [b, f] [1,4] benzothiazepines 11-one and quetiapine methods
05/07/2014CN103772319A 一种硫氮杂卓类化合物的合成方法 A synthesis of compounds thiazepin Zhuo
05/07/2014CN102686602B 羊毛硫氨酸衍生物 Lanthionine derivatives
05/07/2014CN101676275B 一种富马酸喹硫平的制备方法 One kind of method for the preparation of quetiapine fumarate
05/01/2014US20140121368 Process for preparing benzothiazepines from gamma-aminoalkylbenzenes
04/2014
04/30/2014EP2725014A1 Polymorphs of 7-[(3-chloro-6,11-dihydro-6-methyldibenzo[c,f][1,2]thiazepin-11-yl)amino] heptanoic acid S,S dioxide and methods of making and using the same
04/30/2014CN103755663A Process for recycling L-cis-lactam as diltiazem intermediate by-product
04/29/2014US8710045 Agents for preventing and treating disorders involving modulation of the ryanodine receptors
04/16/2014CN103724294A Novel preparation method of quetiapine
04/09/2014CN103717583A Dibenzothiazepine derivatives and their use in the treatment of cns disorders
04/02/2014CN101346357B Aminodihydrothiazine derivative
03/2014
03/27/2014US20140088171 Agents for treating disorders involving modulation of ryanodine receptors
03/27/2014US20140088082 Inhibitors of the plasmodial surface anion channel as antimalarials
03/26/2014CN103664822A Compound used as anesthetic
03/19/2014EP2708535A1 Agents for treating disorders involving modulation of ryanodine receptors
02/2014
02/27/2014WO2014031600A1 Haptens of quetiapine for use in immunoassays
02/26/2014EP2699559A1 Dibenzothiazepine derivatives and their use in the treatment of cns disorders
02/18/2014US8653257 Dibenzothiazepine derivatives and uses thereof—424
02/13/2014WO2014023708A1 Substituted hetero-azepinones
01/2014
01/22/2014CN103524455A 2-chloro-10,11-Dihydro-11-oxodibenzo [b, f] [1, 4] thiazepine-11 (10-H)-one preparing method
01/21/2014CA2717523C Process for preparing benzothiazepines from .gamma.-aminoalkylbenzenes
01/16/2014WO2014009447A1 ARYL SULTAM DERIVATIVES AS RORc MODULATORS
01/16/2014CA2876449A1 Aryl sultam derivatives as rorc modulators
01/09/2014US20140011988 Dibenzo[B,F][1,4]Oxazepin-11-yl-N-Hydroxybenzamides as HDAC Inhibitors
12/2013
12/31/2013US8618283 Ligand libraries for screening GPCRs
12/31/2013US8618282 Process for preparing benzothiazepines from gamma-aminoalkylbenzenes
12/26/2013US20130345410 Novel antibacterial agents
12/17/2013US8609648 Hepatitis C virus inhibitors
12/04/2013CN103420937A Synthesis method of tianeptine sodium
11/2013
11/20/2013EP2664331A1 Novel Antibacterial Agents
11/14/2013US20130303755 Aminodihydrothiazine derivatives
10/2013
10/30/2013CN101977902B Process for preparing benzothiazepines from gamma-aminoalkylbenzenes
10/29/2013CA2605473C Process for preparing quetiapine and quetiapine fumarate
10/24/2013WO2013156505A1 Agents for treating disorders involving modulation of ryanodine receptors
10/23/2013EP2653466A1 Agents for treating disorders involving modulation of ryanodine receptors
10/08/2013CA2667826C Inhibitors of histone deacetylase
09/2013
09/18/2013CN103304515A Preparation method of 11-aminodibenzo[b,f][1,4]thiazepine
09/18/2013CN103304514A Acid diltiazem compound with good stability, and pharmaceutical composition
08/2013
08/15/2013WO2013119564A1 Antibacterial agents: combination of a rifamycin and a switch region inhibitor
08/14/2013CN101500576B Agents for preventing and treating disorders involving modulation of the RYR receptors
08/07/2013CN103232373A Chiral sulfur-containing compound with hexafluoroisopropyl ester based structure as well as synthetic method and application of compound
08/06/2013US8501727 Short acting benzothiazepine calcium channel blockers and uses thereof
07/2013
07/24/2013CN103214431A 2,3-dihydrobenzazapine*compound or its salt and its medical application
07/10/2013EP2612854A1 Aminothiazolidine and aminotetrahydrothiazepine derivatives as BACE 1 inhibitors
07/10/2013CN103201260A Drug derivatives
06/2013
06/05/2013CN101704799B Novel anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof
05/2013
05/29/2013CN101891706B 3,4-dihydrobenzo[f][1,4]thiazepine compound or salts of same and medical use of same
05/15/2013CN103102329A Synthetic method of 2,3-dihydro-[1,4]-benzothiazine compound
05/15/2013CN103102230A O-aminophenyl chiral diallyl sulfide compound and its preparation method
05/01/2013CN101925587B Process for preparation of quetiapine
04/2013
04/16/2013US8420807 Process for the preparation of quetiapine
03/2013
03/20/2013CN102977053A Preparation method of tianeptine sodium impurity D
03/20/2013CN102432562B Quetiapine fumarate compound and new preparation method thereof
03/14/2013US20130065872 Synthesis of syrbactin proteasome inhibitors
03/12/2013US8394790 Psychotropic agents having glutamate NMDA activity
03/07/2013WO2013029136A1 Tianeptine derivatives, pharmaceutical compositions, use, and method for producing same
03/06/2013EP2563122A1 Chemical compounds
03/05/2013US8389716 Process for the synthesis of quetiapine
03/05/2013US8389510 Crystalline forms
02/2013
02/12/2013CA2529817C Novel antibacterial agents
02/07/2013WO2013019978A1 Fluorescence detection of cysteine and homocysteine
02/05/2013US8367656 Polymorphs of 7-[(3-chloro-6,11-dihydro-6-methyldibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoic acid S,S-dioxide used to treat depressive disorders, irritable bowel syndrome, attention deficit hyperactivity disorder, asthma
02/05/2013US8367655 Pyridoindolobenzox—and thiazepine derivatives and uses thereof
01/2013
01/09/2013EP2542537A1 Novel compounds for modulation of orphan nuclear receptor rar-related orphan receptor-gamma (ror gamma, nr1f3) activity and for the treatment of chronic inflammatory and autoimmune disease
01/03/2013WO2013002329A1 Method for producing lanthionine derivative
01/01/2013US8343936 Antibacterial agents
12/2012
12/27/2012US20120328599 Inhibitors of receptor tyrosine kinases (rtk) and methods of use thereof
11/2012
11/21/2012EP2524925A1 Lanthionine derivative
11/14/2012CN101735211B Applications of 2,3-dihydro[1,5] benzothiazepine compounds or salts thereof in preparation of GSK-3beta inhibitor
11/08/2012US20120282386 Lanthionine derivatives
10/2012
10/26/2012WO2012143703A1 Dibenzothiazepine derivatives and their use in the treatment of cns disorders
1 2 3 4 5 6 7 8 9 10 11 ... 20